Literature DB >> 15073486

Macrophages and the kidney.

Heather M Wilson1, David Walbaum, Andrew J Rees.   

Abstract

PURPOSE OF REVIEW: Macrophage infiltration is a hallmark of all forms of inflammatory and non-inflammatory renal injury. However, the classical view of macrophages as cells that cause injury has been superseded with evidence of their heterogeneous role, i.e. with involvement in all stages of the inflammatory process including tissue repair and healing. This review summarizes the major advances in macrophage biology achieved in the last year, highlighting the different activation states, how these are regulated, and their relevance in renal disease. RECENT
FINDINGS: New concepts have emerged concerning the factors controlling monocyte recruitment into inflamed tissue and their subsequent differentiation into activated macrophages. There is now compelling evidence for the heterogeneity of macrophages in clinical disease, i.e. they appear to be able to both promote and downregulate inflammation. An increased understanding of the factors regulating the expression of pro-inflammatory or reparative characteristics by macrophages is establishing how their function can be manipulated to attenuate renal inflammation in experimental models.
SUMMARY: An understanding of the role of macrophages at different time-points in renal inflammation, and the development of techniques for modulating macrophage activation in vivo, will provide a powerful method for exploiting the reparative attributes of these cells in clinical settings, restoring regulation to the inflammatory process and promoting healing.

Entities:  

Mesh:

Year:  2004        PMID: 15073486     DOI: 10.1097/00041552-200405000-00004

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  31 in total

Review 1.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

Review 2.  Immune system in renal injury and repair: burning the candle from both ends?

Authors:  Michael S Goligorsky
Journal:  Pharmacol Res       Date:  2008-06-08       Impact factor: 7.658

3.  N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research.

Authors:  Tang-Dong Liao; Xiao-Ping Yang; Martin D'Ambrosio; Yanlu Zhang; Nour-Eddine Rhaleb; Oscar A Carretero
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

Review 4.  Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities.

Authors:  Young-Myeong Kim; Hyun-Ock Pae; Jeong Euy Park; Yong Chul Lee; Je Moon Woo; Nam-Ho Kim; Yoon Kyung Choi; Bok-Soo Lee; So Ri Kim; Hun-Taeg Chung
Journal:  Antioxid Redox Signal       Date:  2010-10-26       Impact factor: 8.401

Review 5.  Macrophages, dendritic cells, and kidney ischemia-reperfusion injury.

Authors:  Li Li; Mark D Okusa
Journal:  Semin Nephrol       Date:  2010-05       Impact factor: 5.299

6.  Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation.

Authors:  Huaibin Sun; Jun Tian; Wanhua Xian; Tingting Xie; Xiangdong Yang
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

7.  Nephroprotective Effect of Pleurotus ostreatus and Agaricus bisporus Extracts and Carvedilol on Ethylene Glycol-Induced Urolithiasis: Roles of NF-κB, p53, Bcl-2, Bax and Bak.

Authors:  Osama M Ahmed; Hossam Ebaid; El-Shaymaa El-Nahass; Mahmoud Ragab; Ibrahim M Alhazza
Journal:  Biomolecules       Date:  2020-09-14

8.  Targeting sphingosine 1 phosphate receptor type 1 receptors in acute kidney injury.

Authors:  Mark D Okusa; Kevin R Lynch
Journal:  Drug Discov Today Dis Mech       Date:  2007

Review 9.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

10.  Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490.

Authors:  Petya Dimitrova; Valeriya Gyurkovska; Irina Shalova; Luciano Saso; Nina Ivanovska
Journal:  J Inflamm (Lond)       Date:  2009-05-05       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.